Nova Leap Market Risk Adjusted Performance
| NLH Stock | | | CAD 0.32 0.01 3.23% |
Observed values used in the Market Risk Adjusted Performance indicator for Nova Leap Health are included in this dataset. Comparable indicator datasets are structured within
Equity Screeners. Nova Leap has a market cap of 27.94 M, operating margin of 5.07%, current ratio of 0.58. Portfolio-level context is available through
Correlation Analysis. Portfolio analysis tools can evaluate how Nova Leap Health fits within a broader allocation. This information is provided for contextual purposes. Broader economic conditions can influence Nova Leap Health's company valuation — related indicators include
signals in inflation.
Nova Leap Health has current Market Risk Adjusted Performance of
-0.11.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.11 | |
| ER[a] | = | Expected return on investing in Nova Leap |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Nova Leap Health falls in the
fifth position for market risk adjusted performance across the peer group. It is currently under evaluation for maximum drawdown across the peer group .
Other Technical Indicators